-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Reiterates Outperform on Staar Surgical, Maintains $40 Price Target

Benzinga·05/29/2026 13:46:00
Listen to the news
Wedbush analyst Michael Piccolo reiterates Staar Surgical (NASDAQ:STAA) with a Outperform and maintains $40 price target.